R4 Ballot #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.5.0: R4 Ballot #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Medicinalproductingredient-example

Biomedical Research and Regulation Work GroupMaturity Level: N/ABallot Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductIngredient.

Generated Narrative with Details

id: example

role: ActiveBase (Details : {http://ema.europa.eu/example/ingredientRole code 'ActiveBase' = 'ActiveBase)

manufacturer: Organization/example

SpecifiedSubstances

-CodeGroup
*equixabanCompanyequixaban1 (Details : {http://ema.europa.eu/example/specifiedSubstance code 'equixabanCompanyequixaban1' = 'equixabanCompanyequixaban1)2 (Details : {http://ema.europa.eu/example/specifiedSubstanceGroup code '2' = '2)

substance

code: EQUIXABAN (Details : {http://ema.europa.eu/example/substance code 'EQUIXABAN' = 'EQUIXABAN)

Strengths

-
*

 

Other examples that reference this example:

  • MedicinalProductManufactured/General
  • MedicinalProductPharmaceutical/General

    •  

    Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.